Biogen Inc. (BIIB): who owns it and who trades it
As of Nov 16, 2026, BIIB insiders reported 4 open-market sales worth $905K and 1 purchase worth $585 in the last 12 months, with 100% of the sale value made under pre-set 10b5-1 plans. The largest seller was Priya Singhal (Head of Development), with $666K. 8 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Biogen
From the latest filingsOverall: more buying than selling. Congress mostly sold. Insiders and famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns BIIB
1,038 funds and institutions reported BIIB shares worth $30.9B at the end of Q2 2026, about 97% of the company. The largest holder is FMR LLC (Fidelity) with 12.3%.
Funds and institutions (13F) 97%Everyone else 3%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| FMR LLC (Fidelity) | 18.22M | 12.34% | $3.9B | +42% |
| BlackRock, Inc. | 15.99M | 10.83% | $3.5B | +0% |
| Primecap Management Co | 15.15M | 10.26% | $3.3B | +3% |
| Vanguard Capital Management LLC | 9.65M | 6.54% | $2.1B | +1% |
| State Street Corp | 7.34M | 4.97% | $1.6B | +2% |
| Vanguard Portfolio Management LLC | 6.60M | 4.47% | $1.4B | +1% |
| Geode Capital Management, LLC | 4.45M | 3.01% | $958M | +2% |
| Wellington Management Group LLP | 3.12M | 2.11% | $674M | +5% |
| Norges Bank | 2.58M | 1.75% | $557M | – |
| Morgan Stanley | 2.41M | 1.63% | $521M | +11% |
| AQR Capital Management LLC | 1.94M | 1.31% | $417M | +1% |
| JPMorgan Chase & Co | 1.82M | 1.23% | $395M | – |
| Invesco Ltd. | 1.80M | 1.22% | $390M | +3% |
| Amundi | 1.52M | 1.03% | $328M | +92% |
| Legal & General Group Plc | 1.49M | 1.01% | $323M | +11% |
| Northern Trust Corp | 1.43M | 0.97% | $309M | -1% |
| Boston Partners | 1.26M | 0.86% | $273M | -26% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.26M | 0.85% | $271M | -9% |
| Goldman Sachs Group Inc | 1.23M | 0.83% | $266M | +17% |
| Dimensional Fund Advisors LP | 1.15M | 0.78% | $248M | +6% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, BIIB insiders reported $585 of open-market purchases and $905K of sales. 100% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | Lloyd Minor | Director | Sale plan | 593 | $200.96 | $119K | Form 4 |
| Aug 3, 2026 | Lloyd Minor | Director | Sale plan | 593 | $203.34 | $121K | Form 4 |
| Feb 12, 2026 | Nicole Murphy | Head of Pharm Ops and Te | Purchase | 3 | $195.04 | $585 | Form 4 |
| Feb 9, 2026 | Priya Singhal | Head of Development | Sale plan | 2,660 | $199.83 | $532K | Form 4 |
| Feb 2, 2026 | Priya Singhal | Head of Development | Sale plan | 748 | $179.30 | $134K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Priya Singhal | Head of Development | – | $666K | Feb 9, 2026 |
| Lloyd Minor | Director | – | $240K | Aug 4, 2026 |
| Nicole Murphy | Head of Pharm Ops and Tech | $585 | – | Feb 12, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
BIIB short interest
Low short interest. 3.7% of BIIB shares are sold short: about 1 share in 27. Over the last 12 reports the number of shares short went up 15%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 5.45M BIIB shares were sold short, 3.7% of the shares outstanding, down 0.9% from the report before. At the average daily volume of 1.38M shares, buying them all back would take about 4.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 5.45M | 3.69% | -1% | 1.38M | 4.0 |
| Oct 15, 2026 | 5.50M | 3.72% | -8% | 1.25M | 4.4 |
| Sep 30, 2026 | 5.97M | 4.04% | +3% | 1.23M | 4.9 |
| Sep 15, 2026 | 5.82M | 3.94% | +2% | 766,507 | 7.6 |
| Aug 31, 2026 | 5.73M | 3.88% | +10% | 661,593 | 8.7 |
| Aug 14, 2026 | 5.19M | 3.51% | -5% | 847,068 | 6.1 |
| Jul 31, 2026 | 5.45M | 3.69% | -9% | 1.15M | 4.7 |
| Jul 15, 2026 | 6.00M | 4.06% | +5% | 1.74M | 3.5 |
| Jun 30, 2026 | 5.72M | 3.88% | +10% | 1.38M | 4.1 |
| Jun 15, 2026 | 5.19M | 3.51% | +9% | 918,726 | 5.7 |
| May 29, 2026 | 4.77M | 3.23% | +1% | 1.06M | 4.5 |
| May 15, 2026 | 4.73M | 3.20% | +6% | 1.12M | 4.2 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded BIIB
Since Nov 17, 2024, 5 members of Congress reported 8 purchases and 4 sales of BIIB. The latest was a sale by Maria Elvira Salazar on Sep 24, 2026, reported Oct 7, 2026.
Purchases 8Sales 4
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | Maria Elvira Salazar (R-FL) | Partial sale | $1K–$15K | Self | Oct 7, 2026 | Report |
| Aug 18, 2026 | Kevin Hern (R-OK) | Sale | $1K–$15K | Self | Sep 1, 2026 | Report |
| Jun 5, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Jul 2, 2026 | Report |
| Jun 2, 2026 | Maria Elvira Salazar (R-FL) | Sale | $15K–$50K | Self | Jul 7, 2026 | Report |
| May 12, 2026 | Maria Elvira Salazar (R-FL) | Purchase | $1K–$15K | Self | Jun 8, 2026 | Report |
| May 11, 2026 | Maria Elvira Salazar (R-FL) | Purchase | $1K–$15K | Self | Jun 8, 2026 | Report |
| May 11, 2026 | Maria Elvira Salazar (R-FL) | Purchase | $50K–$100K | Self | Jun 8, 2026 | Report |
| Mar 27, 2026 | Alan Armstrong (R-OK) | Purchase | $1K–$15K | Self | Jul 21, 2026 | Report |
| Jan 30, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Feb 13, 2026 | Report |
| May 15, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Purchase | $1K–$15K | Self | Jun 9, 2025 | Report |
| Apr 8, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Sale | $1K–$15K | Self | May 8, 2025 | Report |
| Feb 25, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Purchase | $1K–$15K | Self | Mar 27, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Biogen company events
Biogen filed 12 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Oct 28, 2026.
- Oct 28, 2026ResultsReleased financial results. Filing
- Jul 29, 2026ResultsReleased financial results. Filing
- Jul 1, 2026ResultsReleased financial results. Filing
- Jun 10, 2026VoteReported shareholder vote results. Filing
- May 14, 2026DealPursuant to the Merger Agreement, on April 14, 2026, Purchaser commenced a tender offer to acquire any and all of the issued and outstanding Shares, in exchange for (i) $41.00 per Share, net to the seller in cash, without interest and subject to reduction for any applicable tax withholding, plus… Filing
- Apr 29, 2026ResultsReleased financial results. Filing
- Apr 6, 2026ResultsReleased financial results. Filing
- Mar 31, 2026AgreementBiogen Inc., a Delaware corporation, entered into an Agreement and Plan of Merger with Apellis Pharmaceuticals, Inc., a Delaware corporation, and Aspen Purchaser Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Biogen. Filing
- Mar 11, 2026LeadershipBiogen Inc. announced that Susan H. Alexander, Chief Legal Officer, will depart from the Company effective as of the end May, 2026. Filing
- Feb 11, 2026LeadershipCaroline Dorsa, Chair of the Biogen Inc. Board of Directors announced that she would not stand for re-election to the Board at the 2026 Annual Meeting of Stockholders. Filing
- Feb 6, 2026ResultsReleased financial results. Filing
- Jan 14, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Biogen financials
Famous investors that hold BIIB
8 of the 50 well-known investors we track reported holding BIIB in their latest 13F filing. The largest position is Ken Griffin's, worth $360M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 1.59M | $360M | 0.2% | +281% |
| Ken Fisher · Fisher Asset Management | Q3 2026 | 362,773 | $81.9M | 0.0% | +7% |
| Israel Englander · Millennium Management | Q3 2026 | 242,087 | $54.7M | 0.0% | New |
| Larry Robbins · Glenview Capital Management | Q3 2026 | 68,169 | $15.4M | 0.3% | New |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 26,088 | $5.9M | 0.0% | New |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 3,300 | $745K | 0.0% | -96% |
| Lee Ainslie · Maverick Capital | Q3 2026 | 2,279 | $515K | 0.0% | New |
| Jim Simons · Renaissance Technologies | Q3 2026 | 1,444 | $326K | 0.0% | -98% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named BIIB in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 10, 2026 | STATE STREET CORPORATION | 13G | 5.1% |
| Nov 10, 2026 | STATE STREET CORPORATION | 13G | 5.1% |
Questions about Biogen Inc. (BIIB) stock
Who owns the most BIIB stock?
The largest reported owner of Biogen Inc. (BIIB) is FMR LLC (Fidelity), with 12.3% of the company. In total, 1,038 funds and institutions reported holding BIIB at the end of Q2 2026, together about 97% of the shares. See the largest owners.
Are BIIB insiders buying or selling?
In the last 12 months, BIIB insiders reported 1 open-market purchase worth $585 and 4 sales worth $905K. The latest trade was on Aug 4, 2026. See every trade.
What is the short interest in BIIB?
As of Oct 30, 2026, 5.45M BIIB shares were sold short, 3.7% of the shares outstanding, down 0.9% from the report before. At the average daily volume of 1.38M shares, buying them all back would take about 4.0 trading days (days to cover). See the history.
Have members of Congress traded BIIB?
Yes. 5 members of Congress reported 8 purchases and 4 sales of BIIB since Nov 17, 2024. The latest was reported on Oct 7, 2026. See the trades.
Which famous investors hold BIIB?
8 of the 50 well-known investors we track reported BIIB in their latest 13F filing, including Ken Griffin, Ken Fisher, Israel Englander. The largest position is worth $360M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.